Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation
- 1 October 2001
- journal article
- case report
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (10) , 1720-1731
- https://doi.org/10.1016/s0149-2918(01)80139-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Rapid Release of Antipsychotic Drugs From Dopamine D2 Receptors: An Explanation for Low Receptor Occupancy and Early Clinical Relapse Upon Withdrawal of Clozapine or QuetiapineAmerican Journal of Psychiatry, 1999
- A Bioequivalence Study of Brand and Generic Clozapine in Patients with SchizophreniaClinical Drug Investigation, 1999
- A physician survey on generic drugs and substitution of critical dose medicationsArchives of internal medicine (1960), 1997
- Clozapine in the Back WardsAnnals of Clinical Psychiatry, 1994
- Normal Volunteers Should Not Be Used for Bioavailability or Bioequivalence Studies of ClozapinePharmaceutical Research, 1994
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- No D2 Receptor Increase in PET Study of SchizophreniaArchives of General Psychiatry, 1987